Company intelligence / Profile preview

Frontier Biosolutions

Munich, Germanyfrontierbiosolutions.com ↗

Ownership: Private
Development stage: Other

Overview

Frontier Biosolutions is a global pharmaceutical services investment and operational support platform formed in partnership between KKR and Flerie. It focuses on building value through strategic investments in specialized CRO/CDMO/service providers addressing bottlenecks across the development/manufacturing of advanced therapeutics—including biologics, cell/gene therapies, and vaccines. Its executive leadership comprises industry veterans from leading life science organizations. The company's first publicly announced portfolio company is Coriolis Pharma—a leader in digital formulation R&D for innovative biotherapeutic products.

Modalities: BiologicCell therapyGene therapyVaccine
Industry: Investors

Partnerships

KKR & Co.Flerie Invest AB

Beyond the preview

Go deeper on Frontier Biosolutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frontier Biosolutions.

Explore the full profile